<DOC>
	<DOC>NCT01348360</DOC>
	<brief_summary>The objective of this study is to evaluate effectiveness and safety of Nobori stent in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus- or paclitaxel-eluting stents).</brief_summary>
	<brief_title>Evaluation of Effectiveness and Safety of NOBORI Stent</brief_title>
	<detailed_description>This study is a non-randomized, prospective, open-label registry to compare the efficacy and safety of NOBORI stents versus first-generation DES in patients with coronary artery disease.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients receiving NOBORI stents. The patient or guardian agrees to the study protocol and the schedule of clinical followup, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Patients with a mixture of other DESs. Terminal illness with life expectancy &lt;1 year. Patients with cardiogenic shock.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>